Skip to main content
Top
Published in: European Journal of Pediatrics 9/2009

01-09-2009 | Original Paper

Increased nitric oxide production by neutrophils in early stage of Kawasaki disease

Authors: Ken Yoshimura, Kimiko Tatsumi, Anna Iharada, Shoji Tsuji, Ai Tateiwa, Masayuki Teraguchi, Hirotaro Ogino, Kazunari Kaneko

Published in: European Journal of Pediatrics | Issue 9/2009

Login to get access

Abstract

Recent observations suggested that nitric oxide (NO) has a role in triggering the early endothelial dysfunction in Kawasaki disease (KD). We investigated the amount of NO in conjunction with reactive oxygen species (ROS) produced by neutrophils in children with acute KD by a newly developed flow cytometric analysis. Forty children with acute KD (n = 14), non-KD febrile disease (n = 14), and afebrile control (n = 12) were enrolled (age, 3 to 88 months). Neutrophils in KD produced significantly higher amount of NO compared to others (p < 0.05). With regard to ROS, significant increase was not only found in KD but also in non-KD febrile children (p < 0.05 and p < 0.01, respectively). In KD patients, the amount of NO produced by neutrophils decreased after immunoglobulin (IVIG) treatment, while there was no significant change in ROS production. The amount of NO in KD patients also correlated well with the days from the onset. One patient who developed coronary arterial lesion showed the highest value of NO. In conclusion, neutrophils in acute KD generate both NO and ROS considerably, while NO production is exclusive in the early stage of KD before IVIG treatment. Abnormal immune system in KD might be characterized by an overproduction of NO, whereas the role of NO in endothelial damage remains to be elucidated.
Literature
1.
go back to reference Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F (2003) Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide 8:15–25PubMedCrossRef Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F (2003) Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide 8:15–25PubMedCrossRef
2.
go back to reference Anggard E (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343:199–1206 Anggard E (1994) Nitric oxide: mediator, murderer, and medicine. Lancet 343:199–1206
5.
go back to reference Cheung YF, Huang GY, Chen SB et al (2008) Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122:e608–e614PubMedCrossRef Cheung YF, Huang GY, Chen SB et al (2008) Inflammatory gene polymorphisms and susceptibility to Kawasaki disease and its arterial sequelae. Pediatrics 122:e608–e614PubMedCrossRef
6.
go back to reference Cheung YF, O K, Tam SC, Siow YL (2005) Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr Res 58:1306–1310PubMedCrossRef Cheung YF, O K, Tam SC, Siow YL (2005) Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr Res 58:1306–1310PubMedCrossRef
7.
go back to reference Fang FC (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2:820–832PubMedCrossRef Fang FC (2004) Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2:820–832PubMedCrossRef
8.
go back to reference Hamamichi Y, Ichida F, Xianyi Yu et al (2001) Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease. Pediatr Res 49:74–80PubMedCrossRef Hamamichi Y, Ichida F, Xianyi Yu et al (2001) Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease. Pediatr Res 49:74–80PubMedCrossRef
9.
go back to reference Hobbs MR, Udhayakumar V, Levesque MC et al (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360:1468–1475PubMedCrossRef Hobbs MR, Udhayakumar V, Levesque MC et al (2002) A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet 360:1468–1475PubMedCrossRef
10.
go back to reference Ikemoto Y, Teraguchi M, Ono A, Kino M, Yoshimura K, Kobayashi Y (2003) Serial changes of plasma nitrate in the acute phase of Kawasaki disease. Pediatr Int 45:421–425PubMedCrossRef Ikemoto Y, Teraguchi M, Ono A, Kino M, Yoshimura K, Kobayashi Y (2003) Serial changes of plasma nitrate in the acute phase of Kawasaki disease. Pediatr Int 45:421–425PubMedCrossRef
11.
go back to reference Kojima H, Nakatsubo N, Kikuchi K et al (1998) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70:2446–2453PubMedCrossRef Kojima H, Nakatsubo N, Kikuchi K et al (1998) Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70:2446–2453PubMedCrossRef
12.
go back to reference Kroncke KD, Fehsel K, Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147–156PubMedCrossRef Kroncke KD, Fehsel K, Kolb-Bachofen V (1998) Inducible nitric oxide synthase in human diseases. Clin Exp Immunol 113:147–156PubMedCrossRef
13.
go back to reference Matsubara T, Ichiyama T, Furukawa S (2005) Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 141:381–387PubMedCrossRef Matsubara T, Ichiyama T, Furukawa S (2005) Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 141:381–387PubMedCrossRef
14.
15.
go back to reference Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42PubMedCrossRef Onouchi Y, Gunji T, Burns JC et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42PubMedCrossRef
16.
go back to reference Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo Research Committee on Kawasaki disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo
17.
go back to reference Sato S, Tsukahara H, Ohta N, Todoroki Y, Nishida K, Mayumi M (2004) Endothelial dysfunction in Kawasaki disease: focus on nitric oxide. Pediatr Int 46:114PubMedCrossRef Sato S, Tsukahara H, Ohta N, Todoroki Y, Nishida K, Mayumi M (2004) Endothelial dysfunction in Kawasaki disease: focus on nitric oxide. Pediatr Int 46:114PubMedCrossRef
18.
go back to reference Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T (2003) Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278:3170–3175PubMedCrossRef Setsukinai K, Urano Y, Kakinuma K, Majima HJ, Nagano T (2003) Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species. J Biol Chem 278:3170–3175PubMedCrossRef
19.
go back to reference Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y (2005) Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 47:305–310PubMedCrossRef Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y (2005) Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 47:305–310PubMedCrossRef
20.
go back to reference Terai M, Jibiki T, Harada A et al (1999) Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 65:566–572PubMed Terai M, Jibiki T, Harada A et al (1999) Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatment. J Leukoc Biol 65:566–572PubMed
21.
go back to reference Tsuji S, Taniuchi S, Hasui M, Yamamoto A, Kobayashi Y (2002) Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 7:283–288PubMedCrossRef Tsuji S, Taniuchi S, Hasui M, Yamamoto A, Kobayashi Y (2002) Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 7:283–288PubMedCrossRef
22.
go back to reference Wang CL, Wu YT, Lee CJ, Liu HC, Huang LT, Yang KD (2002) Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediat 141:560–565PubMedCrossRef Wang CL, Wu YT, Lee CJ, Liu HC, Huang LT, Yang KD (2002) Decreased nitric oxide production after intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediat 141:560–565PubMedCrossRef
23.
go back to reference Yu X, Hirono KI, Ichida F et al (2004) Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res 55:688–694PubMedCrossRef Yu X, Hirono KI, Ichida F et al (2004) Enhanced iNOS expression in leukocytes and circulating endothelial cells is associated with the progression of coronary artery lesions in acute Kawasaki disease. Pediatr Res 55:688–694PubMedCrossRef
Metadata
Title
Increased nitric oxide production by neutrophils in early stage of Kawasaki disease
Authors
Ken Yoshimura
Kimiko Tatsumi
Anna Iharada
Shoji Tsuji
Ai Tateiwa
Masayuki Teraguchi
Hirotaro Ogino
Kazunari Kaneko
Publication date
01-09-2009
Publisher
Springer-Verlag
Published in
European Journal of Pediatrics / Issue 9/2009
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0872-1

Other articles of this Issue 9/2009

European Journal of Pediatrics 9/2009 Go to the issue